Skip to main content
OpenTrials
Completed

NCT Number: NCT02705326

Evaluating the Efficacy of Opti-Speech for Speech Treatment

The purpose of this study is to determine if feedback from a three-dimensional real-time visualization of the tongue, a program called Opti-Speech, can be used to improve speech.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Articulation Disorder Articulation Disorders Communication Disorders Deafness Dysarthria Ear Diseases Hearing Disorders Hearing Loss Language Disorders Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Prelingual Deafness Sensation Disorders Signs and Symptoms Speech Disorders

Age range

12 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Cleveland Hearing and Speech Center, Cleveland, Ohio, United States

Loading trial locations.

About this study

Participants will be asked to complete the Goldman Fristoe Test of Articulation along with several other assessment tests. Then speech treatment, guided by Opti-Speech, will be provided to the participant for up to 10 treatment sessions. The participant will be asked to come back after the final treatment for a 2-month follow-up assessment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • English speaking individuals with speech errors resulting from persistent speech sound disorder, individuals with dysarthria resulting from neurological disorders and individuals with pre-lingual or congenital deafness.

Exclusion criteria

  • Cognitive impairments that affect their ability to understand and follow instructions by the treating speech language pathologists

Treatment and study plan

Opti-Speech

Device

Uses visual feedback of the tongue's motion to guide speech sound production

Primary outcomes

  1. Percent articulatory accuracy

    Time frame: within 30 minutes of treatment

    Sound probe lists will be administered within 30 minutes of treatment. Probe lists will be scored as correct or incorrect. The percentage of probes correct will be calculated

Secondary outcomes

  1. Change in Accuracy of Speech Sound Production from Pre-Treatment to Post-Treatment

    Time frame: Immediately prior to first speech treatment and 2 months after final treatment.

    The Goldman Fristoe Test of Articulation will be administered prior to any speech treatment with Opti-Speech and again 2 months after the final speech treatment session. The percentage of consonants correct (PCC) will be used to assess the change in accuracy of speech sound production from pre-treatment to post-treatment

Sponsors and collaborators

Lead sponsor

Vulintus, Inc.

Industry

Collaborators

  • Callier Center for Communication Disorders
  • Case Western Reserve University
  • Cleveland Hearing and Speech Center
  • National Institute on Deafness and Other Communication Disorders (NIDCD)

Registry information

Official study title

Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Mar 10, 2016
Registry last updated
Dec 31, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.